Chairman of the Board of Invalda INVL was elected

The general shareholders meeting of Invalda INVL, which took place on 30 April 2026, elected Alvydas Banys, Indrė Mišeikytė and Tomas Bubinas to the Board for the 4 (four) years term of office. At the Board meeting held on the same day, Alvydas Banys was elected as a Chairman of the Board.

Further information:
Darius Šulnis, CEO of Invalda INVL
[email protected]

You May Also Be Interested In

• Kyungdong Pharmaceutical and Asimov Announce Completion of Cell Line Development Campaign for Biosimilar Antibody
• Innovent Biologics and Daiichi Sankyo Enter Exclusive Agreement for VANFLYTA® Commercialization in China
• Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera